An Open Label, Randomised, Multicentre, Phase IIIb, Parallel Group, Switching Study to Compare the Efficacy and Safety of Lipid Lowering Agents (Atorvastatin, Pravastatin, Simvastatin and Rosuvastatin), in Subjects with Type IIa and Type IIb Hypercholesterolaemia.
Study identifier:D3560C00081 OL
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open Label, Randomised, Multicentre, Phase IIIb, Parallel Group, Switching Study to Compare the Efficacy and Safety of Lipid Lowering Agents (Atorvastatin, Pravastatin, Simvastatin and Rosuvastatin), in Subjects with Type IIa and Type IIb Hypercholesterolaemia.
Medical condition
hypercholesterolaemia
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
